Avid Bioservices to Participate in 18th Annual Morgan Stanley Global Healthcare Conference
Details of the company’s participation are as follows:
- 18th Annual
Morgan Stanley Global Healthcare Conference
Details: Avid management will participate in a fireside chat and 1-on-1 meetings
September 14-18, 2020
Chat Time/Date: 4:15 p.m.Eastern on Thursday, September 17, 2020
A webcast of the fireside chat will be made available. To listen to the live webcast, or access the archived webcast, please visit: http://ir.avidbio.com/investor-events.
Avid Bioservices is a dedicated contract development and manufacturing organization (CDMO) focused on development and CGMP manufacturing of biopharmaceutical drug substances derived from mammalian cell culture. The company provides a comprehensive range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. With 27 years of experience producing monoclonal antibodies and recombinant proteins, Avid's services include CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. For early-stage programs the company provides a variety of process development activities, including upstream and downstream development and optimization, analytical methods development, testing and characterization. The scope of our services ranges from standalone process development projects to full development and manufacturing programs through commercialization. www.avidbio.com.
Stephanie Diaz(Investors) Vida Strategic Partners415-675-7401 firstname.lastname@example.org Tim Brons(Media) Vida Strategic Partners415-675-7402 email@example.com
Source: Avid Bioservices, Inc